Literature DB >> 24673567

Multidisciplinary clinical strategies for encapsulating peritoneal sclerosis in peritoneal dialysis: update from Japan.

Masaaki Nakayama1, Hiroyuki Terawaki.   

Abstract

Peritoneal dialysis is established as a first-line standard renal replacement therapy for end-stage renal disease. However, the development of encapsulating peritoneal sclerosis has been a critical complication among long-term peritoneal dialysis patients. During the past decade, multidisciplinary approaches have been used to suppress encapsulating peritoneal sclerosis. The present article reviews the historical and present status of encapsulating peritoneal sclerosis in Japan.
© 2014 The Japanese Urological Association.

Entities:  

Keywords:  encapsulating peritoneal sclerosis; incremental peritoneal dialysis; neutral solution; peritoneal dialysis; peritoneal dialysis and hemodialysis combination

Mesh:

Year:  2014        PMID: 24673567     DOI: 10.1111/iju.12445

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  2 in total

1.  Dissolved molecular hydrogen (H2) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity.

Authors:  Masaaki Nakayama; Wan-Jun Zhu; Kimio Watanabe; Ayano Gibo; Ali M Sherif; Shigeru Kabayama; Sadayoshi Ito
Journal:  BMC Nephrol       Date:  2017-10-31       Impact factor: 2.388

2.  Delayed administration of suramin attenuates peritoneal fibrosis in rats.

Authors:  Chongxiang Xiong; Na Liu; Xiaofei Shao; Sairah Sharif; Hequn Zou; Shougang Zhuang
Journal:  BMC Nephrol       Date:  2019-11-14       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.